About Express Scripts data
Express Scripts (NASDAQ: ESRX) manages more than a billion prescriptions each year for tens of millions of patients. On behalf of our clients — employers, health plans, unions and government health programs — we make the use of prescription drugs safer and more affordable. Headquartered in St. Louis, Express Scripts provides integrated pharmacy-benefit management services, including network-pharmacy claims processing, home delivery, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
From its inception, Express Scripts has worked to elevate pharmacy benefit management from an understudied component of healthcare to a well-researched, evidence-based discipline. We have always believed that the way to greater value is through greater insight. The path of discovery never ends.
Since 1993, our Research & Analysis department has produced more than 100 abstracts at professional meetings (including the annual Express Scripts Outcomes Research Conference), published dozens of manuscripts in peer-reviewed literature, and generated hundreds of studies to support new and existing products for our clients. In addition, the annual Express Scripts Drug Trend Report, first published in 1997, has earned national recognition as the most comprehensive publicly available examination of U.S. prescription-drug trend. For more information, visit Lab.Express-Scripts.com and www.DrugTrendReport.com or follow @ExpressScripts on Twitter.